National Sleep Therapy Submits Innovation Challenge Proposal

Last week National Sleep Therapy submitted a 70-page proposal to the Centers for Medicare as part of the CMS Healthcare Innovation Challenge. The proposal detailed its plans for substantially expanding its current ECOsystem of patient care that empowers patients and more seamlessly brings together the patient, physician, and CPAP provider.

Shaq Attacks Sleep Apnea

Think it's not cool to wear a breathing mask for chronic snoring? Well, Boston Celtics star Shaquille O'Neal recently got one, and he says -- in the video below produced by Harvard Medical School's Division of Sleep Medicine -- that he intends to wear it every night.

Your Bedtime Habits May Be Causing Your Sleep Problems

"If you're having problems sleeping at night, or if you're feeling too sleepy the next day, take a look at your bedtime habits," says Allison Harvey, PhD, behavioral sleep expert at UC Berkeley. "Create a relaxing wind-down routine and turn down the lights. Make your bedroom a sanctuary from the worries of your day."

Skimping on Sleep Linked to Faster Brain Aging

Folks who get less than seven hours a night have accelerated aging in the brain, according to a study published this week in the journal Sleep. Their cognitive function is on par with someone who's three to seven years older. Surprisingly, getting too much sleep -- more than nine hours a night -- also appears to be linked to speeding the brain's aging process.

Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease

It is primarily over the past 2 to 3 decades that the implications of OSA for cardiovascular disease have become recognized. Nevertheless, the general cardiovascular community has been slow in assimilating OSA into the cardiovascular diagnostic and therapeutic paradigms. This lag between information and intervention can be attributed to a number of factors, including the considerable expense and wait time required for sleep studies, and the variable and sometimes unsuccessful responses to initiation of CPAP therapy. Furthermore, the cardiovascular community is accustomed to management strategies driven by evidence from large-scale randomized trials and has come to regard smaller studies with appropriate caution, even those that show substantial benefit. While the evidence for activation of a broad spectrum of cardiovascular disease mechanisms in patients with OSA is compelling, there are very few longitudinal studies of the effects of OSA on cardiovascular outcomes, and no large-scale, randomized, double-blind trials of the cardiovascular effects of therapeutic intervention.